Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, intergroup study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Mesothelioma
  • Pleural Neoplasms
  • Quality of Life

abstract

  • This study provides important information about the HRQOL of chemotherapy-treated MPM patients.

publication date

  • March 20, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.03.3027

PubMed ID

  • 16446322

Additional Document Info

start page

  • 1435

end page

  • 42

volume

  • 24

number

  • 9